Paper
Treatment options for COVID-19: The reality and challenges
Published Apr 4, 2020 · S. Jean, P.-I. Lee, P. Hsueh
Journal of Microbiology, Immunology, and Infection
440
Citations
26
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Remdesivir shows promise as an antiviral agent for COVID-19, while favipiravir and lopinavir/ritonavir show potential in treating SARS-CoV.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···